# Twenty One Capital, Inc.: financial statements, quarterly

XXI · NYSE · CIK 2070457 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xxi.md) · [Financials](/companies/xxi/financials.md) · [Filings](/companies/xxi/filings.md) · [Insiders](/companies/xxi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xxi/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating income | $m | [(0.4)](/filings/0001213900-26-087471.md) | [(0.1)](/filings/0001213900-25-123918.md) | [(10.6)](/filings/0001213900-26-055938.md) | [(10.7)](/filings/0001213900-26-087471.md) |
| Interest expense | $m | not reported | not reported | [1.3](/filings/0001213900-26-055938.md) | [1.3](/filings/0001213900-26-087471.md) |
| Net income | $m | [(0.4)](/filings/0001213900-26-087471.md) | [(0.1)](/filings/0001213900-25-123918.md) | [(860)](/filings/0001213900-26-087471.md) | [(414)](/filings/0001213900-26-087471.md) |
| Diluted EPS | $ per share | not reported | [(57798.00)](/filings/0001213900-25-123918.md) | not reported | not reported |
| Basic EPS | $ per share | not reported | [(57798.00)](/filings/0001213900-25-123918.md) | not reported | not reported |

- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001213900-25-123918.md) | [118](/filings/0001213900-26-087471.md) | [114](/filings/0001213900-26-055938.md) | [106](/filings/0001213900-26-087471.md) |
| Current assets | $m | not reported | not reported | [118](/filings/0001213900-26-087471.md) | [123](/filings/0001213900-26-055938.md) | [112](/filings/0001213900-26-087471.md) |
| Total assets | $m | not reported | not reported | [3,927](/filings/0001213900-26-087471.md) | [3,075](/filings/0001213900-26-055938.md) | [2,664](/filings/0001213900-26-087471.md) |
| Current liabilities | $m | [0.0](/filings/0001213900-25-123918.md) | [0.1](/filings/0001213900-25-123918.md) | [2.5](/filings/0001213900-26-087471.md) | [4.9](/filings/0001213900-26-055938.md) | [1.6](/filings/0001213900-26-087471.md) |
| Total liabilities | $m | [0.0](/filings/0001213900-25-123918.md) | [0.1](/filings/0001213900-25-123918.md) | [487](/filings/0001213900-26-087471.md) | [489](/filings/0001213900-26-055938.md) | [486](/filings/0001213900-26-087471.md) |
| Shareholders' equity | $m | [(0.2)](/filings/0001213900-26-087471.md) | [(0.1)](/filings/0001213900-25-123918.md) | [3,440](/filings/0001213900-26-087471.md) | [2,585](/filings/0001213900-26-087471.md) | [2,178](/filings/0001213900-26-087471.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Operating cash flow | $k | [(3,646)](/filings/0001213900-26-055938.md) | [(7,925) d](/filings/0001213900-26-087471.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: |
| Diluted shares (weighted) | units of shares | [1.0](/filings/0001213900-25-123918.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.